Influence of genetic polymorphism on t,t-MA/S-PMA ratio in 301 benzene exposed subjects

Toxicology Letters

Volumn 231, Issue 2, 2014, Pages 205-212

  Carbonari, Damiano ^a   Proietto, Annarita ^a   Fioretti, Marzia ^a   Tranfo, Giovanna ^a   Paci, Enrico ^a   Papacchini, Maddalena ^a   Mansi, Antonella ^a  

^a DEPARTMENT OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE   (Italy)

Author keywords

Benzene exposure; Genetic polymorphism; Risk assessment; Smoking; t,t MA S PMA ratio

Indexed keywords

BENZENE; CREATININE; CYTOCHROME P450 1A; CYTOCHROME P450 2E1; EPOXIDE; GLUTATHIONE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MUCONIC ACID; RESTRICTION ENDONUCLEASE; S PHENYL MERCAPTURIC ACID; TRANS TRANS MUCONIC ACID; UNCLASSIFIED DRUG; ACETYLCYSTEINE; PETROLEUM; S-PHENYL-N-ACETYLCYSTEINE; SORBIC ACID;

ALCOHOL CONSUMPTION; ARTICLE; CONJUGATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; ITALY; KIDNEY CONCENTRATING CAPACITY; MAXIMUM ALLOWABLE CONCENTRATION; METABOLITE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SMOKING HABIT; ADULT; ANALOGS AND DERIVATIVES; FEMALE; GENE EXPRESSION REGULATION; INDUSTRY; MALE; METABOLISM;

ACETYLCYSTEINE; ADULT; BENZENE; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INDUSTRY; MALE; OCCUPATIONAL EXPOSURE; PETROLEUM; POLYMORPHISM, GENETIC; SMOKING; SORBIC ACID;

EID: 84921365930     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.06.029     Document Type: Article

References (37)

1. ACGIH Threshold Limit Values and Biological Exposure Indices 2013, ACGIH, Cincinnati.
2. Angelini S., Kumar R., Bermejo J.L., Maffei F., Barbieri A., Graziosi F., Carbone F., Cantelli-Forti G., Violante F.S., Hemminki K., Hrelia P. Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes. Mutat. Res. 2011, 719:7-13.
3. Arnold S.M., Angerer J., Boogaard P.J., Hughes M.F., O'Lone R.B., Robison S.H., Schnatter A.R. The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit. Rev. Toxicol. 2013, 43(2):119-153.
4. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998, 58(23):5291-5293.
5. Cascorbi I., Brockmöller J., Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996, 56(21):4965-4969.
6. Chen H., Lum A., Seifried A., Wilkens L.R., Le Marchand L. Association of the NAD(P)H:quinone oxidoreductase 609C→T polymorphism with a decreased lung cancer risk. Cancer Res. 1999, 59(13):3045-3048.
7. Chen Y., Li G., Yin S., Xu J., Ji Z., Xiu X., Liu L., Ma D. Genetic polymorphisms involved in toxicant-metabolizing enzymes and the risk of chronic benzene poisoning in Chinese occupationally exposed populations. Xenobiotica 2007, 37(1):103-112.
8. Chen J., Cheng M., Li Y., Jiang C.B. Relationship Between CYP1A1 Genetic Polymorphisms and Renal Cancer in China. Asian Pac. J. Cancer Prev. 2011, 12:2163-2166.
9. Coles B.F., Morel F., Rauch C., Huber W.W., Yang M., Teitel C.H., Green B., Lang N.P., Kadlubar F.F. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001, 11(8):663-669.
10. Dougherty D., Garte S., Barchowsky A., Zmuda J., Taioli E. NQO1, MPO, CYP2E1 and GSTM1 polymorphisms and biological effects of benzene exposure - a literature review. Toxicol. Lett. 2008, 182(1-3):7-17.
11. Fustinoni S., Consonni D., Campo L., Buratti M., Colombi A., Pesatori A.C., Bonzini M., Bertazzi P.A., Foà V., Garte S., Farmer P.B., Levy L.S., Pala M., Valerio F., Fontana V., Desideri A., Merlo D.F. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking, and genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2005, 14(9):2237-2244.
12. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stücker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001, 10(12):1239-1248.
13. Garte S., Taioli E., Popov T., Bolognesi C., Farmer P., Merlo F. Genetic susceptibility to benzene toxicity in humans. J. Toxicol. Environ. Health A 2008, 71:1482-1489.
14. Gobba F., Rovesti S., Borella P., Vivoli R., Caselgrandi E., Vivoli G. Inter-individual variability of benzene metabolism to trans,trans-muconic acid and its implications in the biological monitoring of occupational exposure. Sci. Total Environ. 1997, 199(1-2):41-48.
15. Gsur A., Zidek T., Schnattinger K., Feik E., Haidinger G., Hollaus P., Mohn-Staudner A., Armbruster C., Madersbacher S., Schatzl G., Trieb K., Vutuc C., Micksche M. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br. J. Cancer 2003, 89(4):702-706.
16. Hardy G.H. Mendelian proportions in a mixed population. Science 1908, 28:49-50.
17. Harrison D.J., Hubbard A.L., MacMillan J., Wyllie A.H., Smith C.A.D. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Brit. J. Cancer 1999, 79(1):168-171.
18. Kim S., Lan Q., Waidyanatha S., Chanock S., Johnson B.A., Vermeulen R., Smith M.T., Zhang L., Li G., Shen M., Yin S., Rothman N., Rappaport S.M. Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet. Genomics 2007, 17(10):789-801.
19. Larsen J.E., Colosimo M.L., Yang I.A., Bowman R., Zimmerman P.V., Fong K.M. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 2006, 27(3):525-532.
20. Le Marchand L., Seifried A., Lum A., Wilkens L.R. Association of the myeloperoxidase-463G→a polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2000, 9(2):181-184.
21. Lin L.C., Chen W.J., Chiung Y.M., Shih T.S., Liao P.C. Association between GST genetic polymorphism and dose-related production of urinary benzene metabolite markers, trans,trans-muconic acid and S-phenylmercapturic acid. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1460-1469.
22. Manini P., De Palma G., Andreoli R., Mozzoni P., Poli D., Goldoni M., Petyx M., Apostoli P., Mutti A. Occupational exposure to low levels of benzene: biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes. Toxicol. Lett. 2010, 193(3):229-235.
23. Mansi A., Bruni R., Capone P., Paci E., Pigini D., Simeoni C., Gnerre R., Papacchini M., Tranfo G. Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t,t-MA/S-PMA ratio. Toxicol. Lett. 2012, 213:57-62.
24. Paci E., Pigini D., Cialdella A.M., Faranda P., Tranfo G. Determination of free and total S-phenylmercapturic acid by HPLC/MS/MS in the biological monitoring of benzene exposure. Biomarkers 2007, 12:111-122.
25. Pittilo M. Cigarette smoking, endothelial injury and cardiovascular disease. Int. J. Exp. Pathol. 2000, 81(4):219-230.
26. Qu Q., Shore R., Li G., Su L., Jin X., Melikian A.A., Roy N., Chen L.C., Wirgin I., Cohen B., Yin S., Li Y., Mu R. Biomarkers of benzene: urinary metabolites in relation to individual genotype and personal exposure. Chem. Biol. Interact. 2005, 153-154:85-95.
27. Ross D. The role of metabolism and specific metabolites in benzene induced toxicity. J. Toxicol. Environ. Health 2000, A61:357-372.
28. Ross D. Functions and distribution of NQO1 in human bone marrow: Potential clues to benzene toxicity. Chem. Biol. Interact. 2005, 153-154:137-146.
29. Rossi A.M., Guarnieri C., Rovesti S., Gobba F., Ghittori S., Vivoli G., Barale R. Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics. 1999, 9(4):445-451.
30. Snyder R., Witz G., Golstein B.D. The toxicology of benzene. Environ. Health Perspect. 1993, 100:293-306.
31. Sonzogni L., Silvestri L., De Silvestri A., Gritti C., Foti L., Zavaglia C., Bottelli R., Mondelli M.U., Civardi E., Silini E.M. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Hepatology 2002, 36:195-201.
32. Sorensen M., Skov H., Autrup H., Hertel O., Loft S. Urban, benzene exposure and oxidative DNA damage: influence of genetic polymorphisms in metabolism genes. Sci. Total Environ. 2003, 309:69-80.
33. Sorensen M., Poole J., Autrup H., Muzyka V., Jensen A., Loft S., Knudsen L.E. Benzene exposure assessed by metabolite excretion in Estonian oil shale mineworkers: influence of glutathione S-transferase polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1729-1735.
34. Toth K.M., Berger E.M., Beehler C.J., Repine J.E. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am. Rev. Respir. Dis. 1986, 134:281-284.
35. Tranfo G., Paci E., Sisto R., Pigini D. Validation of an HPLC/MS/MS method with isotopic dilution for quantitative determination of trans,trans-muconic acid in urine samples of workers exposed to low benzene concentrations. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 867:26-31.
36. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., Huang W., Xia Z., Hu G. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ. Health Perspect. 2002, 110:1213-1218.
37. WHO, 1996. Biological Monitoring of Chemical Exposure in the Workplace, vol. 1. World Health Organization, Geneva.